Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

Regulatory & Legal View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹5000.00

prior close

₹4994.90

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.9%+1.8% vs market

Pharmaceuticals peers, median of 149sector-0.9%+1.9% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Midcap 150 and 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.5

15m

+0.4

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0-0.9+1.8-0.9+1.9

Next day

+1.6-0.0+1.6+0.2+1.4

+2.1+0.2+1.9+0.1+2.0

+0.6-0.7+1.2-0.6+1.1

-3.0-1.9-1.1-2.8-0.2

-2.0-0.8-1.2-1.9-0.0

-3.2-1.9-1.3-4.3+1.1

15d

+8.0-0.2+8.2-3.7+11.7

+7.2-3.0+10.2-6.5+13.7

+9.1-2.2+11.4-7.7+16.8

+8.8+2.6+6.2-6.6+15.4

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has received an order from the Deputy Commissioner of Revenue, State Tax, Bureau of Investigation (North Bengal), Alipurduar Zone, West Bengal, imposing a penalty of Rs. 40,74,186 (about Rs. 40.74 lakhs) under the IGST Act, 2017. The penalty relates to technical discrepancies in documents carried by a transporter for a goods consignment detained by the authorities. The order was received on 25th July 2025. The company has stated that there is no material impact on its financial, operational, or other activities.

Likely market impact

The penalty amount of roughly Rs. 41 lakhs is small relative to a large pharma company's operations, and the company itself says there is no material impact. Shareholders are unlikely to see any meaningful effect on earnings or stock price from this order.